Provided by Tiger Trade Technology Pte. Ltd.

CHINARES PHARMA

4.450
+0.0200.45%
Volume:8.27M
Turnover:36.75M
Market Cap:27.96B
PE:8.39
High:4.510
Open:4.490
Low:4.410
Close:4.430
52wk High:5.668
52wk Low:4.340
Shares:6.28B
HK Float Shares:6.28B
Volume Ratio:0.74
T/O Rate:0.13%
Dividend:0.14
Dividend Rate:3.16%
EPS(LYR):0.530
ROE:7.57%
ROA:2.66%
PB:0.49
PE(LYR):8.39
PS:0.09

Loading ...

China Resources Pharmaceutical Group Appoints Wan Wing Yi Carol as Company Secretary

Reuters
·
Dec 15, 2025

What China Resources Pharmaceutical Group (SEHK:3320)'s Onshore Debt Refinancing Plan Means For Shareholders

Simply Wall St.
·
Dec 03, 2025

CHINARES PHARMA (03320) Subsidiary Approved to Issue RMB 3 Billion Medium-Term Notes

Stock News
·
Dec 01, 2025

China Resources Pharmaceutical Group Subsidiary Registers RMB3 Billion Medium Term Notes Offering

Reuters
·
Dec 01, 2025

China Resources Pharmaceutical - Unit Receives Notice of Registration Acceptance in Relation to Issuance of Medium Term Notes

THOMSON REUTERS
·
Dec 01, 2025

China Resources Pharmaceutical Group Ltd - Cr Pharmaceutical Commercial May Issue Medium Term Notes up to RMB3 Bln

THOMSON REUTERS
·
Dec 01, 2025

China Resources Pharmaceutical Group Limited (03320) Announces Monthly Return for November 2025

Bulletin Express
·
Dec 01, 2025

China Resources Pharmaceutical Group Limited (3320) Proposes Amendments to Articles of Association

Bulletin Express
·
Nov 27, 2025

Mauna Kea Technologies Secures NMPA Approval for Cellvizio Gen 3 Platform in China

Reuters
·
Nov 21, 2025

CHINARES PHARMA (03320) Subsidiary Completes Issuance of RMB1.1 Billion Corporate Bonds

Stock News
·
Nov 18, 2025

China Resources Pharmaceutical Group Completes RMB1.1 Billion Corporate Bond Issuance

Reuters
·
Nov 18, 2025

China Resources Pharmaceutical Group Limited (03320) Announces Monthly Movements in Securities for October 2025

Bulletin Express
·
Nov 04, 2025

Is China Resources Pharmaceutical Group (HKG:3320) Using Too Much Debt?

Simply Wall St.
·
Nov 01, 2025

Hong Kong Stock Announcement Highlights | GTHT Reports 220.74 Billion Yuan Net Profit in First Three Quarters, Up 131.8% YoY

Stock News
·
Oct 30, 2025

BRIEF-China Resources Pharmaceutical Says Fund Established With Proposed Size Of RMB500 Mln

Reuters
·
Oct 30, 2025

CR Pharma (3320) and CR Double-Crane (600062) Announce RMB500 Million Biomedical Fund

Bulletin Express
·
Oct 30, 2025

CHINARES PHARMA (03320) Leads Establishment of RMB 500 Million Fund, Focusing on Synthetic Biology and Innovative Drugs

Stock News
·
Oct 30, 2025

China Resources Pharmaceutical Group Ltd - Commits RMB123 Mln to Fund

THOMSON REUTERS
·
Oct 30, 2025

China Resources Pharmaceutical Group - Fund Established With Proposed Size of RMB500 Mln

THOMSON REUTERS
·
Oct 30, 2025

BRIEF-China Resources Pharmaceutical Says 9M Net Profit For CR Boya Bio-Pharmaceutical At RMB343 Million

Reuters
·
Oct 27, 2025